Search results for "dab"

showing 10 items of 1280 documents

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention

2016

ABSTRACTIntroduction: Non vitamin-K oral anticoagulants (NOACs) are direct and specific inhibitors of the coagulation factors IIa (dabigatran) and Xa (apixaban, rivaroxaban, edoxaban) which share many pharmacokinetic properties. However, indications are lacking regarding the use of NOACs during thrombolysis, surgery and bleeding events.Areas covered: In this paper, the authors retrospectively analyzed the relevant literature on the NOACs using the PubMed and Google Scholar databases.Expert commentary: Although warfarin is effective in cardioembolic stroke prevention, easier handling and more favorable risk-benefit profile often render NOACs a more preferable therapy choice for neurologists.…

medicine.medical_specialtyVitamin KPyridonesaspirinmedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematologyDabigatranAnticoagulation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdoxabanmedicineHumansatrial fibrillationPharmacology (medical)030212 general & internal medicineIntensive care medicineRivaroxabanAspirinbusiness.industryGeneral Neurosciencenon vitamin-K oral anticoagulantWarfarinAnticoagulantsreverse therapyAtrial fibrillationThrombolysismedicine.diseasemeasure of monitoringStrokewarfarinchemistryAnesthesiaPyrazolesApixabanstroke preventionNeurology (clinical)businessmedicine.drugExpert Review of Neurotherapeutics
researchProduct

Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants

2010

An increasing number of patients receive anticoagulant therapy to prevent and treat arterial or venous thromboembolism. The major complication of anticoagulant therapy is the increase of the individual bleeding risk. All anticoagulant drugs can cause haemorrhages, that can sometimes be life-threatening. Although heparins and the vitamin K antagonists have been the most widely used anticoagulants for decades, the correct management of bleeding complications associated with these agents has been poorly studied. More recently, new anticoagulant drugs, both parenteral and oral, have been approved for clinical use. Currently, none of these new agents has a specific antidote, and little advise ca…

medicine.medical_specialtyVitamin Kmedicine.drug_classMorpholinesHemorrhageFactor VIIaThiophenesVitamin kFondaparinuxDabigatranRivaroxabanPolysaccharidesRisk FactorsDrug DiscoverymedicineHumansProtaminesIntensive care medicinePharmacologyRivaroxabanHeparinbusiness.industryAntithrombinAnticoagulantAnticoagulantsHeparinRecombinant ProteinsDabigatranFondaparinuxbeta-AlanineBenzimidazolesComplicationbusinessBleeding anticoagulantsmedicine.drugCurrent Pharmaceutical Design
researchProduct

Gastrointestinal disorders and dabigatran.

2012

Anticoagulants play an important role in the prevention and treatment of a variety of acute and chronic thromboembolic disorders such as primary prevention and treatment of venous thromboembolism or prevention of stroke and systemic embolism in atrial fibrillation just to name of few. Within recent years, a promising new oral anticoagulant, the direct thrombin inhibitor dabigatran etexilate (dabigatran) successfully underwent clinical development and has emerged as an alternative to vitamin K antagonists according to a variety of recently revised and updated international guidelines referring to the indication of stroke prevention in atrial fibrillation. Considering the intensive clinical u…

medicine.medical_specialtybusiness.industryPyridinesGastroenterologyAnticoagulantsAtrial fibrillationVitamin kmedicine.diseaseDabigatranDabigatranStrokeDirect thrombin inhibitorStroke preventionAnesthesiaAtrial FibrillationmedicineOral anticoagulantHumansBenzimidazolesDyspepsiabusinessIntensive care medicineStrokeVenous thromboembolismmedicine.drugScandinavian journal of gastroenterology
researchProduct

Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score

2021

ObjectivesCurrent international guidelines advocate the application of bleeding risk scores only to identify modifiable risk factors, but not to withhold treatment in patients at high risk of bleeding. VTE-BLEED (ActiVe cancer, male with uncontrolled hyperTension, anaEmia, history of BLeeding, agE and rEnal Dysfunction) is a simple bleeding risk score that predicts major bleeding (MB) in patients with venous thromboembolism, but has never been evaluated in patients with atrial fibrillation (AF). We sought to evaluate VTE-BLEED in patients with AF included in the Randomised Evaluation of Long-term anticoagulant therapY (RE-LY) trial, to assess whether score classes (high vs low bleeding risk…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk Scorebusiness.industry10031 Clinic for AngiologyIncidence (epidemiology)PopulationCancer610 Medicine & healthAtrial fibrillation030204 cardiovascular system & hematologymedicine.diseaseDabigatran03 medical and health sciences0302 clinical medicineInternal medicineRelative riskMedicineatrial fibrillation030212 general & internal medicineCardiology and Cardiovascular MedicinebusinesseducationStrokemedicine.drug
researchProduct

Patient-centered web-based information on oral lichen planus : quality and readability

2019

Background To assess the readability and quality of web-based information available for patients about oral lichen planus (OLP). Material and Methods Three major search engines (Google, Bing and Yahoo!) were used to identify websites of particular interest to the study using the search term ‘oral lichen planus’. The first 100 sites of each search engine were considered for the study. The quality of the contents was evaluated using the DISCERN instrument. The Flesch-Kinkaid Reading Grade Level (FKRGL) and the Flesh Reading Ease Score (FRES) were used to assess readability. The presence of the Health on the Net (HON) seal was also evaluated. Results Following the application of the study’s ex…

medicine.medical_specialtymedia_common.quotation_subjectMEDLINE03 medical and health sciences0302 clinical medicineReading (process)Patient-Centered CaremedicineWeb applicationHumansQuality (business)Medical physicsGeneral Dentistrymedia_commonInternetOral Medicine and Pathologybusiness.industryResearch030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseReadabilityTest (assessment)ComprehensionSearch EngineOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusbusinessPsychologyComprehensionLichen Planus Oral
researchProduct

Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry

2021

Thrombosis and haemostasis 122(4), 552-559 (2022). doi:10.1055/a-1549-6556

medicine.medical_specialtymedicine.drug_classPyridonesAdministration OralHemorrhagePharmacokineticsRivaroxabanInternal medicineAtrial FibrillationmedicineHumansProspective StudiesRegistriesRivaroxabanbusiness.industryAnticoagulantAnticoagulantsHematologyEmergency situationsConfidence intervalDabigatranClinical trialApixabanObservational studybusinessmedicine.drug
researchProduct

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

2020

Background Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Thereby, patients with acute ischemic stroke who are on dabigatran treatment may become eligible for thrombolysis with recombinant tissue-type plasminogen activator (rt-PA). In patients on dabigatran with intracerebral hemorrhage idarucizumab could prevent lesion growth. Aims To provide insights into the clinical use of idarucizumab in patients under effective dabigatran anticoagulation presenting with signs of acute ischemic stroke or intracranial hemorrhage. Methods Retrospective data collected from German neurological/neurosurgical departments ad…

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentMedizinAntibodies Monoclonal HumanizedAntithrombinsBrain IschemiaDabigatranGermanyInternal medicinemedicineHumansThrombolytic Therapyddc:610Ischemic StrokeRetrospective StudiesIntracerebral hemorrhagebusiness.industryAnticoagulantWarfarinIdarucizumabAtrial fibrillationThrombolysisVitamin K antagonistmedicine.diseaseDabigatranStrokeNeurologyCardiologybusinessIntracranial Hemorrhagesmedicine.drugInternational Journal of Stroke
researchProduct

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

2018

BACKGROUND AND PURPOSE Whereas intravenous thrombolysis (IVT) is allowed for acute ischaemic stroke in patients on vitamin K antagonists with international normalized ratio ≤1.7, there are no similar recommendations for patients on direct oral anticoagulants (DOACs), notably due to the lack of coagulation tests to assess the therapeutic effects. Although the literature is scarce, consisting of small case series and retrospective studies, considering the frequency of this situation the French Vascular Neurology Society and the French Study Group on Haemostasis and Thrombosis have worked on a joint position paper to provide a practical position regarding the emergency management of ischaemic …

medicine.medical_specialtymedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematologyAntithrombinsDabigatranBrain Ischemia03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanAtrial FibrillationCoagulation testingMedicineHumansThrombolytic TherapyStrokeRetrospective StudiesProthrombin timeRivaroxabanmedicine.diagnostic_testbusiness.industryAnticoagulantsIdarucizumabThrombolysismedicine.diseaseDabigatranStrokeNeurologyEmergency medicineAdministration IntravenousNeurology (clinical)Blood Coagulation Testsbusiness030217 neurology & neurosurgeryPartial thromboplastin timemedicine.drugFactor Xa InhibitorsEuropean journal of neurology
researchProduct

Encapsulation of Vitamins A and E as Spray-Dried Additives for the Feed Industry

2020

Encapsulated fat-soluble powders containing vitamin A (VA) and E (VE) were prepared as a feasible additive for extruded feed products. The effect of the encapsulating agents (Capsul-CAP&reg

medicine.medical_treatmentPharmaceutical Science02 engineering and technologyAnalytical Chemistrychemistry.chemical_compoundSpectroscopy Fourier Transform InfraredDrug DiscoveryVitamin E03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesVitamin ACalorimetry Differential ScanningTemperatureSpray Drying04 agricultural and veterinary sciences021001 nanoscience & nanotechnologyMaltodextrin040401 food science02.- Poner fin al hambre conseguir la seguridad alimentaria y una mejor nutrición y promover la agricultura sostenibleChemistry (miscellaneous)Spray dryingThermogravimetryMAQUINAS Y MOTORES TERMICOSMolecular MedicineEmulsionsExtrusionPowders0210 nano-technologyOxidation-ReductionPorosityMaterials scienceNanoemulsionsDrug CompoundingSodiumChemical structureSpray-dryingchemistry.chemical_elementArticle14.- Conservar y utilizar de forma sostenible los océanos mares y recursos marinos para lograr el desarrollo sosteniblelcsh:QD241-4410404 agricultural biotechnologylcsh:Organic chemistrymedicineThermal stabilityParticle SizePhysical and Theoretical ChemistryPorosityVitamin EOrganic ChemistryHumidityChemical engineeringchemistryDietary SupplementsNanoparticlesEncapsulationMolecules
researchProduct

VECĀKĀ PIRMSSKOLAS VECUMA BĒRNU MATEMĀTISKO PRIEKŠSTATU VEICINĀŠANA DARBĪBĀS AR DABAS MATERIĀLIEM

2017

Bakalaura darba autore: Zaiga Kļaviņa Bakalaura darba tēma: Vecākā pirmsskolas vecuma bērnu matemātisko priekšstatu veicināšana darbībās ar dabas materiāliem. Darba apjoms: 56 lapas, 8 attēli, 6 tabulas, 1 pielikums, 26 literatūras vienības. Atslēgas vārdi: matemātiskie priekšstati, skaits un skaitīšana, metodes un paņēmieni, dabas materiāli. Pētījuma mērķis: teorētiski un praktiski pētīt vecākā pirmsskolas vecuma bērnu matemātisko priekšstatu veidošanos darbībās ar dabas materiāliem. Bakalaura darba saturs: 1.Teorētiskā daļā pētīta un analizēta pedagoģiskā un psiholoģiskā literatūra par 5 – 6 gadu vecu bērnu vecumposma īpatnībām un matemātisko priekšstatu veidošanos; 2.Pētījumā izvērtētas …

metodes un paņēmienimatemātiskie priekšstatiskaits un skaitīšanaSkolas pedagoģijadabas materiāli
researchProduct